Liaoning Chengda Biotechnology Co., Ltd. (SHA:688739)
China flag China · Delayed Price · Currency is CNY
20.01
-0.22 (-1.09%)
At close: Nov 17, 2026

SHA:688739 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
64.97131.79342.82465.92714.02892.49
Depreciation & Amortization
175.01175.01172.18125.27121.22116.1
Other Amortization
7.657.653.813.712.221.32
Loss (Gain) From Sale of Assets
00-0.09-2.48-0.04-0.01
Asset Writedown & Restructuring Costs
81.1781.171.80.870.830.71
Loss (Gain) From Sale of Investments
-67.36-67.3660.0220.27-27.25-14.2
Provision & Write-off of Bad Debts
8.448.448.6612.7715.0816.44
Other Operating Activities
119.4539.633.2155.437.988.11
Change in Accounts Receivable
18.3918.39-18.0213.82-156.41-436.49
Change in Inventory
-52.76-52.76-73.270.42-104.11-109.74
Change in Accounts Payable
-2.71-2.71-27.59-11.84-17.5545.15
Change in Other Net Operating Assets
0.130.130.060.060.080.1
Operating Cash Flow
353.89340.86500.96677.01546.49506.38
Operating Cash Flow Growth
-7.07%-31.96%-26.00%23.88%7.92%-41.09%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-160.32-308.08-362.48-551.99-511.61-508.35
Sale of Property, Plant & Equipment
-0010.980.020.150.02
Cash Acquisitions
-0.13-0.13-0.06-0.06-0.08-0.09
Investment in Securities
-2,092154.4156.81-883.23,327-2,598
Other Investing Activities
28.5826.9431.9232.9575.0440.72
Investing Cash Flow
-2,224-126.88-162.83-1,4022,890-3,066

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--6.51-5.85-6.38-5.41-5.63
Lease Payments
-6.51-6.51-5.85-6.38-5.41-5.63
Net Debt Issued (Repaid)
-6.51-6.51-5.85-6.38-5.41-5.63
Issuance of Common Stock
-----4,371
Repurchase of Common Stock
-10.79-10.79-50-99.99--
Common Dividends Paid
-41.15-329.23-329.38-416.32-416.3-
Dividends Paid
-41.15-329.23-329.38-416.32-416.3-
Other Financing Activities
22.12-----18.95
Financing Cash Flow
-36.33-346.53-385.23-522.69-421.74,347

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2.870.690.552.291.58-0.36
Net Cash Flow
-1,909-131.86-46.55-1,2463,0171,787

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
193.5832.78138.48125.0234.89-1.97
Free Cash Flow Growth
634.85%-76.33%10.76%258.36%--
Free Cash Flow Margin
14.47%2.36%8.26%7.14%1.92%-0.09%
Free Cash Flow Per Share
0.470.080.340.300.08-0.01
Levered Free Cash Flow
7.38-170.6852.1346.39-182.35-228.08
Unlevered Free Cash Flow
8.18-169.7953.1147.28-181.53-227.12
Free Cash Flow After Leases
187.0726.27132.63118.6429.48-7.6

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
132.4594.29177.45182.09211.18198.48
Change in Working Capital
-35.44-35.44-121.46-4.75-287.57-514.57